Author:
Cawello Willi,Bonn Rainer,Boekens Hilmar
Subject
Pharmacology,General Medicine
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration?;Int. Journal of Clinical Pharmacology and Therapeutics;2024-03-01
2. Lacosamide dosing in patients receiving continuous renal replacement therapy;Journal of Intensive Care;2023-11-09
3. Multi-centric Phase III, single-arm, open-label clinical study to assess clinical safety, tolerability, and efficacy of intravenous lacosamide in focal onset seizures;F1000Research;2023-08-24
4. Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial;Epilepsia Open;2023-01-18
5. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity;Trials;2022-09-05